We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0J2O Halozyme Therapeutics Inc

0.00 (0.00%)
27 Feb 2024 - Closed
Delayed by 15 minutes

Halozyme Therapeutics Financial Summary

The current 0J2O market cap is 2.41B. The company's latest EPS is USD 1.5301 and P/E is 26.04.

Year End 31 December 2022 20182019202020212022
Total Revenue 151.86M195.99M267.59M443.31M660.12M
Operating Income -69.33M-67.61M144.26M275.9M267.53M
Net Income -80.33M-72.24M129.09M402.71M202.13M
Year End 31 December 2022 20182019202020212022
Total Assets 440.25M565.87M579.92M1.1B1.84B
Total Liabilities 191.36M474.11M428.88M907.48M1.67B
Total Equity 248.89M91.77M151.05M196.95M169.8M

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating -49.5M-85.42M55.45M299.44M240.11M
Investing 2.49M-5.55M78.35M-406.29M-487.01M
Financing -63.8M153.22M-106.28M77.87M362.37M
Market Cap 2.41B
Price to Earnings Ratio 26.04
Price to Sales Ratio 7.97
Price to Cash Ratio 22.47
Price to Book Ratio 30.99
Dividend Yield -

Share Statistics

Shares Outstanding 132.1M
Average Volume (1 week) 1.79k
Average Volume (1 Month) 2.51k
52 Week Change 0.00%
52 Week High 18.26
52 Week Low 18.26
Spread (Intraday) 0 (0%)

Company Info

Company Name Halozyme Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |